Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Feb 8 GMED Steris (STE) Lags Q3 Earnings and Revenue Estimates
Feb 8 BBIO Why 2023 is shaping up as a critical year for drug makers (Hint: It has something to do with cash)
Feb 8 TGTX Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here'
Feb 8 BBIO BridgeBio Pharma to Participate in February and March Investor Events
Feb 7 TGTX TG Therapeutics (TGTX) Stock Sinks As Market Gains: What You Should Know
Feb 7 ICLR Why Icon PLC (ICLR) is Poised to Beat Earnings Estimates Again
Feb 7 SAGE Sage and Biogen's NDA for Depression Drug Gets Priority Review
Feb 7 TGTX TG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapy
Feb 6 SAGE Sage Therapeutics-Biogen Partnered Depression Candidate Under Priority FDA Review, Analyst Says Its 'Incrementally Positive'
Feb 6 SAGE FDA grants Priority Review to depression drug; Sage’s stock rallies
Feb 6 SAGE Biogen, Sage win FDA priority review for depression therapy
Feb 6 ICLR ICON plc: Market Repricing Higher, Revising To Buy At 33x Forward P/E
Feb 6 SAGE Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Feb 6 SAGE Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Feb 3 GMED Strength Seen in Nevro (NVRO): Can Its 5.1% Jump Turn into More Strength?
Feb 3 RETA Reata Pharmaceuticals, Inc. (RETA) Soars 6.3%: Is Further Upside Left in the Stock?
Feb 2 GMED Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
Feb 2 FGEN FibroGen to Present at SVB Securities Global Biopharma Conference
Feb 2 SAGE Sage Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
Clinical Development

Browse All Tags